VAHA, >=98% (HPLC)

VAHA, >=98% (HPLC)

Application

VAHA may be used in cell signaling studies.

Biochem/physiol Actions

Hydroxamic acid derivatives of valproic acid exhibit anticonvulsant activity with no teratogenic activity in mouse neural tube defect model. It is effective in the treatment of bipolar disorders.

VAHA (Valproyl hydroxamic acid) is an HDAC inhibitor with less activity than valproic acid against Class I enzymes but much greater Class II activity

Features and Benefits

This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3573974 VAHA, >=98% (HPLC) 100 ROJGIRXXBBBMPL-UHFFFAOYSA-N 1S/C8H17NO2/c1-3-5-7(6-4-2)8(10)9-11/h7,11H,3-6H2,1-2H3,(H,9,10) SIGMA-ALDRICH 2-8°C DMSO: ≥25 mg/mL powder ≥98% (HPLC)
£447.11 (exc VAT) per 25MG
-
+
3573975 VAHA, >=98% (HPLC) 100 ROJGIRXXBBBMPL-UHFFFAOYSA-N 1S/C8H17NO2/c1-3-5-7(6-4-2)8(10)9-11/h7,11H,3-6H2,1-2H3,(H,9,10) SIGMA-ALDRICH 2-8°C DMSO: ≥25 mg/mL powder ≥98% (HPLC)
£153.21 (exc VAT) per 5MG
-
+